Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cue Biopharma (CUE) Return on Capital Employed (2018 - 2025)

Cue Biopharma's Return on Capital Employed history spans 8 years, with the latest figure at 1.85% for Q3 2025.

  • For Q3 2025, Return on Capital Employed fell 14.0% year-over-year to 1.85%; the TTM value through Sep 2025 reached 1.85%, down 14.0%, while the annual FY2024 figure was 1.25%, 37.0% down from the prior year.
  • Return on Capital Employed for Q3 2025 was 1.85% at Cue Biopharma, up from 3.22% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.58% in Q1 2021 and bottomed at 3.51% in Q1 2025.
  • The 5-year median for Return on Capital Employed is 0.86% (2023), against an average of 1.24%.
  • The largest annual shift saw Return on Capital Employed rose 13bps in 2021 before it crashed -221bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.64% in 2021, then dropped by -15bps to 0.74% in 2022, then tumbled by -47bps to 1.08% in 2023, then crashed by -54bps to 1.67% in 2024, then decreased by -10bps to 1.85% in 2025.
  • Per Business Quant, the three most recent readings for CUE's Return on Capital Employed are 1.85% (Q3 2025), 3.22% (Q2 2025), and 3.51% (Q1 2025).